Biochemical diagnosis of monomeric hyperprolactinemia;Diagnóstico bioquímico de la hiperprolactinemia monomérica

Anales del Sistema Sanitario de Navarra

Volumn 34, Issue 2, 2011, Pages 145-152

  Rivero, A ^a   Garcia Calvo A ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

Macroprolactin; Monomeric prolactin; Polyethylene Glycol; Prolactin; Reference values

Indexed keywords

MACROGOL; PROLACTIN;

ARTICLE; BLOOD SAMPLING; FEMALE; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HYPERPROLACTINEMIA; MAJOR CLINICAL STUDY; MALE; MONOMERIC HYPERPROLACTINEMIA; REFERENCE VALUE;

EID: 84856015391     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1137-66272011000200002     Document Type: Article

References (30)

1. Comisión de interferencias y efectos de los medicamentos. Recomendaciones sobre las interferencias por macroprolactina en la medición de prolactina. Sociedad Española de Bioquímica Clínica. Comité Científico. Química Clínica 2006; 25: 45-49.
2. Fahie Wilson MN, John R, Ellis AR. Macroprolactin; high molecular mass forms of circulating prolactin. Ann Clin Biochem 2005; 42: 75-92.
3. Diver MJ, Ewins DL, Worth R, Bowles S, Ahlquist J, Fahie-Wilson MN et al. An unusual form of big, big (macro) prolactin in a pregnant patient. Clin Chem 2001; 47: 346-348.
4. Kilvington F, Rahim A, Kavanagh L, Smith T, Fahie Wilson M. False negative PEG precipitation test in a case of hyperprolactinaemia with an IgA macroprolactin. Ann Clin Biochem 2006; 43 (Suppl 1):A35.
5. Whittaker PG, Wilson T, Lind T. Maintained fertility in a patient with hyperprolactinemia due to big big prolactin. J Clin Endocrinol Metab 1981; 53: 833-836.
6. Suliman AM, Smith TP, Gibney J, Mckenna TJ. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin Chem 2003; 49: 1504-1509.
7. Beltran L, Fahie-Wilson MN, Mckenna TJ, Kavanagh L, Smith TP. Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassay platforms. Clin Chem 2008; 54: 1673-1681.
8. Fahie-Wilson MN. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem 1997; 34: 252-258.
9. Olukoga A, Kane J. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol 1999; 51: 119-126.
10. Vieira JG. Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia. Clin Chem 1998; 44: 1758-1759.
11. Rivero A, Alonso E, Grijalba A. Decision cut-off of the polyethylene glycol precipitation technique in screening for macroprolactinemia on Immulite 2000. Clin Chem Lab Med 2004; 42: 566-568.
12. Solberg HE. Establishment and Use of Reference Values. En: Burtis CA, Ashwood ER, editor. Tietz Textbook of Clinical Chemistry. Philadelphia: Saunders, 1994: 454-484.
13. Leaños-Miranda A, Chávez-Rueda KA, Blanco-Favela F. Biologic activity and clearance of prolactin-IgG complex in patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 866-875.
14. Hattori N. Anti-Prolactin (PRL) Autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRLImmunoglobulin G complex. J Clin Endocrinol Metabol 1997; 82: 3107-3110.
15. Vallette-Kasic S, Morange I, Selim A, Gunz G, Morange S, Enjalbert A, et al. Macroprolactinemia revised: A Study on 106 Patients. J Clin Endocrinol Metab 2001; 87: 581-588.
16. Leslie H, Courtney C, Bell P, Hadden D, Mccance D, Ellis P, et al. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 2001; 86: 2743-2746.
17. Fideleff HL, Ruibal G, Boquete H, Pujol A, Sequera A, Sobrado P. Macroprolactinemia in childhood and adolescence: a cause of asymptomatic hyperprolactinemia. Horm Res 2000; 53: 16-19.
18. Wallace R, Satti N, Courtney CH, Leslie H, Bell PM, Hunter SJ, et al. Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant. J Clin Endocrinol Metab 2010; 95: 3268-3271.
19. Mckenna TJ. Should macroprolactin be measured in all hyperprolactinaemic sera. Clin Endocrinol 2009; 71: 466-469.
20. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol 2006; 65: 265-273.
21. Fahie-Wilson MN, Ahlquist JA. Hyperprolactinaemia due to macroprolactins: some progress but still a problem. Clin Endocrinol 2003; 58: 683-685.
22. John R, McDowell IF, Scanlon MF, Ellis AR. Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers Clin Chem 2000; 46: 884-885.
23. Fahie-Wilson MN. Detection of macroprolactin causing hyperprolactinemia in commercial assays for prolactin. Clin Chem 2000; 46: 2022-2023.
24. Gilson G, Schmit P, Thix J, Hoffman JP, Humbel RL. Prolactin results for samples containing macroprolactin are method and samples dependent. Clin Chem 2001; 47: 331-333.
25. Ellis AR, Fahie-Wilson MN, Axcell M, Sands K, Hill RP. Macroprolactin(s): composition and reactivity in immunoassays and laboratory interpretation of results of an unusual patient serum. Ann Clin Biochem 2006; 43: 57-62.
26. Li W, Sustarsic D, Fahie Wilson M, Vankrieken L, Quero K, Del Rosario I et al. Matrix effect of PEG precipitation in detection of macroprolactin in Immulite and Immulite 2000 Prolactin assay. Clin Chem 2002; 48 (Suppl 6):A62.
27. Rivero A. Polyethylene glycol interference in the Immulite prolactin assay: treatment of the calibrators with PEG does not improve diagnostic accuracy. Clin Chem Lab Med 2008; 46: 296-297.
28. Kavanagh L, Mckenna TJ, Fahie-Wilson MN, Gibney J, Smith TP. Specificity and clinical utility of methods for the detection of macroprolactin. Clin Chem 2006; 52: 1366-1372.
29. Ellis A, Fahie Wilson M. Hyperprolactinaemia caused by antipsychotic drugs: a new application for prolactin assay. Ann Clin Biochem 2010; 47: 287-289.
30. Jassam NF, Paterson A, Lippiatt C, Barth JH. Macroprolactin on the Advia Centaur: experience with 409 patients over a three-year period. Ann Clin Biochem 2009; 46: 501-504.